YHLO_YHLO News

Congrats! YHLO Received CE mark on COVID-19 Ag Self-Test Kit

Time Posted : 2021-12-23

YHLO Receives FDA 510(K) Clearance for iFlash 1800 Chemiluminescence Immunoassay Analyzer and iFlash Total βhCG Assay

Time Posted : 2021-12-16

EU COVID-19 Rapid Antigen Tests Common List Inclusion of YHLO GLINE-2019-nCoV Ag

Time Posted : 2021-12-09

YHLO Showcased Its Latest iFlash CLIA at MEDICA 2021

Time Posted : 2021-11-16

Great inheritance of YHLO iFlash Series, new product being installed

Time Posted : 2021-11-03

One more YHLO - Beckman Coulter joint automation system installed

Time Posted : 2021-10-28

YHLO received its first IVDR, paving the way for EU IVD market

Time Posted : 2021-10-26

YHLO Joined Hands With Peking University In Molecular Diagnosis

Time Posted : 2021-10-25

...

Home

About YHLO

Products

Services

News

Company Profile Milestone Corporate Values

About YHLO

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers. In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

More +

Clinical Solution CLIA ELISA LIA POCT ESR COVID-19

Products

Based on the technology platforms of CLIA, ELISA, LIA and immunofluorescence, YHLO is specialized in diagnosis of autoimmunity, reproductive health, diabetes, infectious diseases etc.

More +